The UK breast-screening programme should start at age 47 years [2]

Lancet

Volumn 362, Issue 9379, 2003, Pages 246-247

  Sasieni, Peter ^a   Cuzick, Jack ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; DIAGNOSTIC ACCURACY; HUMAN; LETTER; MAMMOGRAPHY; PRIORITY JOURNAL; SCREENING; UNITED KINGDOM;

EID: 0038445590     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13922-0     Document Type: Letter

References (3)

1. Tabar L., Yen M.F., Vitak B., Chen H.H., Smith R.A., Duffy S.W. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 361:2003;1405-1410.
2. Hendrick R.E., Smith R.A., Rutledge J.H. 3rd, Smart C.R. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr. 22:1997;87-92.
3. Nystrom L., Andersson I., Bjurstam N., Frisell J., Nordenskjold B., Rutqvist L.E. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 359:2002;909-919.